
Nicola Crosetto. Photo: Stefan Zimmerman
Researchers at Karolinska Institutet have developed a technology for cost-effective surveillance of the global spread of new SARS-CoV-2 variants. The technique is presented in the scientific journal Nature Communications.
Since the onset of the pandemic, thousands of viral genomes have been sequenced to reconstruct the evolution and global spread of the coronavirus. This is important for the identification of particularly concerning variants that are more contagious, pathogenic, or resistant to the existing vaccines.
For global surveillance of the SARS-CoV-2 genome, it is crucial to sequence and analyse many samples in a cost-effective way. Therefore, researchers in the Bienko-Crosetto laboratory at Karolinska Institutet and Science for Life Laboratory (SciLifeLab) in Sweden have developed a new method, named COVseq, that can be used for surveillance of the viral genome on a massive scale at a low cost.
Adapted a previous method
First, many copies of the viral genome are created using so-called multiplex PCR (polymerase chain reaction). The samples are then labelled and pooled together in the same sequencing library, using a previous method developed in the Bienko-Crosetto laboratory and now adapted for SARS-CoV-2 analysis.
“By performing reactions in very small volumes and pooling together hundreds of samples into the same sequencing library, we can sequence potentially thousands of viral genomes per week at a cost of less than 15 dollars per sample,” says Ning Zhang, who previously worked as a postdoctoral researcher at the Department of Medical Biochemistry and Biophysics, Karolinska Institutet and is co-first author together with PhD students Michele Simonetti and Luuk Harbers active at the same department.
Comparative analyses of 29 SARS-CoV-2 positive samples revealed that COVseq had a similar ability as the standard method to identify small changes in the genome. Analyses of 245 additional samples showed that COVseq also had a high ability to detect emergent coronavirus variants of potential concern. The key advantage of COVseq over existing methods is cost-effectiveness.
Could be used by public health agencies
“Our inexpensive method could immediately be used for SARS-CoV-2 genomic surveillance by public health agencies and could also be easily adapted to other RNA viruses, such as influenza and dengue viruses,” says Nicola Crosetto, senior researcher at the Department of Medical Biochemistry and Biophysics, Karolinska Institutet, and last author of the paper.
Original Article: Low-cost method for finding new coronavirus variants
More from: Karolinska Institutet
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
SARS-CoV-2 variants
- New Covid variant Pirola explained: BA.2.86's characteristics, transmissibility, vaccine efficacy and more
The global pandemic of Covid-19, stemming from the SARS-CoV-2 virus, has witnessed multiple waves propelled by diverse variants. In the ongoing battle against the virus, a recent variant, BA.2.86, ...
- A long-acting biologic with transmucosal transport properties that arrest SARS-CoV-2 virus variants
When the COVID-19 pandemic first started, no effective anti-viral drugs were available to fight the disease. However, in record time, so-called monoclonal antibodies were developed as a lifesaving ...
- What To Know About Rapidly Spreading ‘Pirola’ Covid Variant BA.2.86—And If Vaccines Offer Protection
Pirola quickly spread across the U.S., with cases almost tripling in number from the previous two-week period.
- COVID variant BA.2.86 triples in new CDC estimates, now 8.8% of cases
However, this latest estimate – 8.8% through Nov. 25 – is virtually triple what it was on Nov. 11, when 3.0% of new cases were estimated to be BA.2.86. The CDC typically publishes its variant ...
- New insights into how SARS-CoV-2 evades our immune system
This review in Cellular and Molecular Immunology delves into the innate immune response to SARS-CoV-2, exploring how the virus evades immunity and the potential role of innate immunity in long-COVID ...
Go deeper with Google Headlines on:
SARS-CoV-2 variants
[google_news title=”” keyword=” SARS-CoV-2 variants” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
SARS-CoV-2 genomic surveillance
- Genomic surveillance of SARS-CoV-2 in Weihai, China, march 2022 to march 2023
Weihai was also affected during this period. We conducted genomic surveillance of SARS-CoV-2 variants in Weihai during this period, hoping to understand the changes in the genomic characteristics of ...
- NGS solutions for genomic surveillance of SARS-CoV-2
To help you accelerate your SARS-CoV-2 genomic surveillance efforts, we’ve developed two tailored solutions for viral amplification and NGS library preparation. The faster you can sequence samples, ...
- Accelerate SARS-CoV-2 Genomic Surveillance With Rapid, High-Throughput NGS
high-performance NGS solution for SARS-CoV-2 genomic surveillance and variant detection. This dramatically faster, high-throughput SARS-CoV-2 NGS solution enables targeted whole genome library ...
- Accelerate SARS-CoV-2 Genomic Surveillance With Rapid, High-Throughput NGS
high-performance NGS solution for SARS-CoV-2 genomic surveillance and variant detection. This dramatically faster, high-throughput SARS-CoV-2 NGS solution enables targeted whole genome library ...
- QIAseq SARS-CoV-2 Primer Panel
The QIAseq SARS-CoV-2 Primer Panel is intended for molecular biology applications. This product is not intended for the diagnosis, prevention, or treatment of a disease.
Go deeper with Google Headlines on:
SARS-CoV-2 genomic surveillance
[google_news title=”” keyword=”SARS-CoV-2 genomic surveillance” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]